Table 1.
Correlation of Rab27A expression with clinicopathological characteristics of 112 CRC patients
| Groups | No. | Rab27A | χ2 | p value | |
|---|---|---|---|---|---|
| + | % | ||||
| Gender | 1.1835 | 0.277 | |||
| Male | 73 | 39 | 53.4 | ||
| Female | 39 | 25 | 64.1 | ||
| Age (years) | 0.0133 | 0.908 | |||
| ≥60 | 74 | 42 | 56.8 | ||
| <60 | 38 | 22 | 57.9 | ||
| Tumor size (cm) | 0.4585 | 0.498 | |||
| ≥5 | 47 | 25 | 53.2 | ||
| <5 | 62 | 37 | 59.7 | ||
| Insufficient data | 3 | 2 | |||
| Tumor location | 1.9870 | 0.370 | |||
| Colon | 57 | 32 | 56.1 | ||
| Rectum | 51 | 31 | 60.8 | ||
| Ileocecal junction | 4 | 1 | |||
| Histological type | 2.3425 | 0.126 | |||
| Adenocarcinoma | 102 | 56 | 54.9 | ||
| Non-adenocarcinoma | 10 | 8 | 80.0 | ||
| Tumor differentiation | 3.3634 | 0.186 | |||
| Well | 1 | 0 | 0.0 | ||
| Moderately | 92 | 55 | 59.8 | ||
| Poorly | 15 | 6 | 40.0 | ||
| Insufficient data | 4 | 3 | |||
| Serum CEA level (ng/ml) | 0.2855 | 0.593 | |||
| ≥15 | 14 | 7 | 50.0 | ||
| <15 | 71 | 41 | 57.7 | ||
| Insufficient data | 27 | 16 | |||
| T (Primary tumor) | 3.0490 | 0.218 | |||
| T1 | 7 | 6 | 85.7 | ||
| T2 | 26 | 16 | 61.5 | ||
| T3 | 79 | 42 | 53.2 | ||
| N (Lymph node metastasis) | 5.2438 | 0.022* | |||
| Positive | 44 | 31 | 70.5 | ||
| Negative | 68 | 33 | 48.5 | ||
| M (Distant metastasis) | 0.6280 | 0.428 | |||
| Positive | 5 | 2 | 40.0 | ||
| Negative | 107 | 62 | 57.9 | ||
| TNM stage | 9.2855 | 0.026* | |||
| Stage I | 29 | 18 | 62.1 | ||
| Stage II | 36 | 14 | 38.9 | ||
| Stage III | 42 | 30 | 71.4 | ||
| Stage IV | 5 | 2 | 40.0 | ||
*p < 0.05